Celgene (CELG) Announces Presentation of GED-0301 Phase 1b Data in Active Crohn’s Disease
Tweet Send to a Friend
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (Nasdaq: CELG), announced that data from a randomized, double-blind, multicenter, exploratory ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE